comparemela.com

Douglas Tsao News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Roivant Sciences Ltd (NASDAQ:ROIV) Q4 2023 Earnings Call Transcript

Roivant Sciences Ltd (NASDAQ:ROIV) Q4 2023 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Frank tortiMatt glineDavid risingerDouglas tsaoMayukh sukhatmeYaron werberAbby beierBristol myers squibbCorinne johnsonAndy chenLouise chenYatin sunejaPiper sandlerBrian chengAllison bratzelWolfe research

scPharmaceuticals Inc (NASDAQ:SCPH) Q1 2024 Earnings Call Transcript

scPharmaceuticals Inc (NASDAQ:SCPH) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoGlen santangeloStacy kuRoanna ruizJohn tuckerSteve parsonsDouglas tsaoNaz rahmanRachael nokesUniversity of californiaYork heart association classNaz rahman at maxim groupPharmaceuticals first quarterPharmaceuticals incScpharmaceuticals inc

7 Analysts Assess Alkermes: What You Need To Know

Throughout the last three months, 7 analysts have evaluated Alkermes (NASDAQ:ALKS), offering a diverse set of opinions from bullish to bearish. Th.

Ashwani vermaAkash tewariDavid amsellemPiper sandlerDouglas tsaoJoel beattyAnalyst firmHc wainwright coHealth careAnalyst ratingsCapitalization analysis

Daré Bioscience, Inc (NASDAQ:DARE) Q4 2023 Earnings Call Transcript

Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.12.

United statesWhite houseDistrict of columbiaDouglas tsaoJill bidenSabrina martucci johnsonMardee haring laytonWhite house initiative on women health researchWhite house gender policy councilDare bioscience incBioscience incDevelopment agreementCall transcript marchFourth quarter financial resultsGeneral businessChief executive officer

Theravance Biopharma, Inc (NASDAQ:TBPH) Q4 2023 Earnings Call Transcript

Theravance Biopharma, Inc. beats earnings expectations. Reported EPS is $0.03, expectations were $-0.04.

City ofUnited kingdomUnited statesRick winninghamDouglas tsaoTheravance biopharmaDavid risingerRhonda farnumAziz sawafHead of developmentTheravance biopharma incNational institutes of healthDepartment of neurosciencesCall transcript februaryTheravance biopharma fourth quarterChief executive

vimarsana © 2020. All Rights Reserved.